Overview
Jake focuses on healthcare law, and his work encompasses a range of regulatory, transactional and corporate matters. He counsels clients with regard to the legal aspects of day-to-day operations, including general corporate matters; anti-kickback and Stark issues; self-referral, corporate practice of medicine and fee-splitting prohibitions; compliance; state regulatory and licensure matters; and HIPAA and health information privacy.
Jake regularly represents a variety of dialysis and nephrology providers, vascular access center operators and owners, hospitals, physician group practices, infusion therapy owners and operators, behavior health providers, skilled nursing facilities, healthcare information technology companies and other healthcare providers in structuring mergers and acquisitions, joint ventures, accountable care and capitated care arrangements, syndications and divestitures.
Jake was recognized by his peers in the 2025 edition of Best Lawyers: Ones to Watch® in America for his exceptional work in Health Care Law.
Earlier in Jake’s career, he practiced as a litigator for Chicago-based law firms. He also has served as staff assistant to U.S. Senator Tom Harkin and to the Senate Committee on Health, Education, Labor and Pensions.
Featured endorsements
Credentials
Education
- Order of the Barristers
- Dean’s List
Bar & Court Admissions
More
- Listed, The Best Lawyers in America®: Ones to Watch, Health Care Law, 2024-2025
Related News & Insights
AI in the Infusion Suite: What Infusion Providers Need to Know Now
AI in healthcare is rapidly expanding beyond large systems, raising critical HIPAA compliance and data security considerations. Learn how infusion providers can adopt AI technologies safely, legally, and in alignment with evolving healthcare regulations.
California Court Could Upend the Continuity Planning Agreements That Hold MSO-PC Structures Together
A case now pending before a California appellate court could directly threaten the contractual foundation that management services organization-professional corporation (“MSO-PC”) and dental services organization-professional corporation (“DSO-PC”) platforms rely on.
The LEAD Model—Kidney Care’s Value-Based Care Journey LEADs Here
For more than a decade, nephrology practices have participated in Innovation Center kidney‑focused models—beginning with ESRD Seamless Care Organizations (“ESCOs”) under the Comprehensive ESRD Care (“CEC”) Model (2015–2021), followed by today’s Kidney Care Choices (“KCC”) Model (2022–2027). With KCC scheduled to end in December 2027, kidney care providers are approaching a critical transition point. The Long‑term Enhanced ACO Design (“LEAD”) Model, for which CMS released the Request for Applications (“RFA”) on March 31, 2026 (revised April 15, 2026), represents the next phase of CMS’s value‑based care strategy—but it differs fundamentally from the kidney‑specific models that preceded it.
Benesch Healthcare+ Dialysis & Nephrology Digest No. 74
Speaking & Events
Past Events
Non-Compete Legislation Update, Dialysis and Nephrology Industry Issues, Considerations and Current Trends in Value Based Care and Practice Aggregation | Jake A. Cilek, Nesko Radovic
Denver, CO
Understanding Fraud and Abuse Risks and Learning from Past Government Enforcement Actions | Mark J. Silberman, Jake A. Cilek, Nicholas E. Adamson
Lombard, IL